Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-16
DOI
10.3389/fendo.2021.708494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
- (2021) Sabrina Schlesinger et al. DIABETOLOGIA
- Parkinson’s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Cynthia Putri et al. PARKINSONISM & RELATED DISORDERS
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can we contain the COVID-19 outbreak with the same measures as for SARS?
- (2020) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study
- (2020) Gian Paolo Fadini et al. DIABETES OBESITY & METABOLISM
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes and COVID‐19
- (2020) Zachary T. Bloomgarden Journal of Diabetes
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards
- (2020) Michael A. Nauck et al. DIABETES CARE
- Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
- (2020) Rocky Strollo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
- (2020) Chia Siang Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
- (2020) Bo Yu et al. Cell Metabolism
- Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
- (2020) Jean-Daniel Lalau et al. DIABETES & METABOLISM
- COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
- (2020) Harald Sourij et al. DIABETES OBESITY & METABOLISM
- Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study
- (2020) Nan Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19
- (2020) Jiang-Hua Zhou et al. World Journal of Clinical Cases
- Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells
- (2019) Ameet K. Mishra et al. LEUKEMIA
- Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity
- (2019) Karla Schoen et al. BMC INFECTIOUS DISEASES
- Metformin reverses established lung fibrosis in a bleomycin model
- (2018) Sunad Rangarajan et al. NATURE MEDICINE
- Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis
- (2018) Saul Soberanes et al. Cell Metabolism
- Insulin-Treated Patients with Diabetes Mellitus Undergoing Emergency Abdominal Surgery Have Worse Outcomes than Patients Treated with Oral Agents
- (2016) Tobias Haltmeier et al. WORLD JOURNAL OF SURGERY
- Diabetes and infection: assessing the association with glycaemic control in population-based studies
- (2016) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia
- (2016) Gouri Rani Banik et al. VIROLOGICA SINICA
- Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review
- (2014) Xinghua Xu et al. BMC Womens Health
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Intensive versus Conventional Glucose Control in Critically Ill Patients
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now